US EditionPublished • loading... • Updated
Research Analysts Set Expectations for NTLA FY2030 Earnings
Brookline Capital Management projects Intellia Therapeutics to earn $75.05 per share in FY2030, diverging sharply from the consensus loss estimate of $5.07 per share.
Summary
1 Articles
1 Articles
Analysts Set Expectations for electroCore FY2025 Earnings
electroCore, Inc. (NASDAQ:ECOR – Free Report) – Investment analysts at HC Wainwright lifted their FY2025 EPS estimates for electroCore in a research note issued to investors on Monday, January 26th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of ($1.62) per share for the year, up from their previous estimate of ($1.63). HC Wainwright currently has a “Buy” rating and a $18.00 target price on the stock. The c…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
